Combined vial of BPC-157 (5 mg) and TB-500 (5 mg) for recovery-focused research protocols.
⚠ For research use only · Not for human use · Not FDA approved
A short research-handling guide for BPC-157 5mg + TB-500 5mg. For laboratory and research use only.
Combined vial of BPC-157 (5 mg) and TB-500 (5 mg) for recovery-focused research protocols.
BPC-157 5mg + TB-500 5mg is supplied as a lyophilized (freeze-dried) powder. Reconstitute it before research use. Recommended diluent: bacteriostatic water.
Example: 2 ml of diluent in this 10 mg vial gives 5,000 mcg/ml. A 250 mcg research amount is then 0.05 ml (5 units on a U-100 syringe) — about 40 doses per vial.
Most commonly referenced in published research at 250–500 mcg, once daily. Reference only — not a dosing instruction.
Keep lyophilized vials frozen and out of light. Once reconstituted, refrigerate (2–8 °C) and use within a few weeks. Always use sterile technique.
For laboratory and research use only. Not for human or veterinary use, food, or drug applications.